What is the latest DIVISLAB stock price?
The latest stored price for DIVISLAB is Rs 11,080.00 as of 2026-11-16.
DIVI S LABORATORIES LTD is a large-cap stock in Healthcare. This Gimli page shows the latest available DIVISLAB price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for DIVISLAB is Rs 11,080.00 as of 2026-11-16.
DIVISLAB is above 50DMA, above 200DMA. The latest 50DMA is 9,624.60 and the latest 200DMA is 7,533.93.
DIVISLAB has PE 87.46, ROE +21.13%, and ROCE +28.10% in Gimli's latest available snapshot.
DIVISLAB has returned +21.17% over 1 month, +30.71% over 3 months, and +70.16% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 3,676.00 cr | 1,660.00 cr | 1,127.00 cr | 42.49 |
| 2026-06-30 | 3,037.00 cr | 1,303.00 cr | 891.00 cr | 33.95 |
| 2026-03-31 | 2,831.00 cr | 1,089.00 cr | 751.00 cr | 28.31 |
| 2025-12-31 | 2,604.00 cr | 904.00 cr | 583.00 cr | 21.98 |
| 2025-09-30 | 2,860.00 cr | 1,033.00 cr | 689.00 cr | 25.97 |
| 2025-06-30 | 2,410.00 cr | 848.00 cr | 545.00 cr | 20.49 |
| 2025-03-31 | 2,585.00 cr | 972.00 cr | 662.00 cr | 24.93 |
| 2024-12-31 | 2,319.00 cr | 825.00 cr | 589.00 cr | 22.20 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 10,560.00 cr | 3,874.00 cr | 2,568.00 cr | 96.75 |
| 2025-03-31 | 9,360.00 cr | 3,320.00 cr | 2,191.00 cr | 82.53 |
| 2024-03-31 | 7,796.00 cr | 2,544.00 cr | 1,600.00 cr | 60.27 |
| 2023-03-31 | 7,665.00 cr | 2,712.00 cr | 1,824.00 cr | 68.69 |
| 2022-03-31 | 8,991.08 cr | 3,995.38 cr | 2,948.54 cr | 111.07 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 20,033.00 cr | 128.00 cr | 7.00 cr | 16,761.00 cr |
| 2025-03-31 | 16,932.00 cr | 415.00 cr | 4.00 cr | 14,969.00 cr |
| 2024-03-31 | 15,470.00 cr | 363.00 cr | 3.00 cr | 13,571.00 cr |
| 2023-03-31 | 14,439.00 cr | 170.00 cr | 4.00 cr | 12,767.00 cr |
| 2022-03-31 | 13,374.71 cr | 1,214.76 cr | 3.69 cr | 11,728.18 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 2,738.00 cr | 218.00 cr | n/a |
| 2025-03-31 | 1,653.00 cr | 215.00 cr | n/a |
| 2024-03-31 | 1,261.00 cr | 258.00 cr | n/a |
| 2023-03-31 | 2,459.00 cr | 1,986.00 cr | n/a |
| 2022-03-31 | 1,911.80 cr | 1,198.60 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +51.88% | +20.38% | +19.17% | +14.66% | +8.58% | +0.00% |
| 2026-06-30 | +51.88% | +20.20% | +19.38% | +13.87% | +8.54% | +0.00% |
| 2026-03-31 | +51.88% | +20.29% | +19.22% | +13.42% | +8.60% | +0.00% |
| 2025-12-31 | +51.88% | +20.08% | +19.28% | +13.73% | +8.76% | +0.00% |
| 2025-09-30 | +51.89% | +19.39% | +19.76% | +13.99% | +8.96% | +0.00% |
| 2025-06-30 | +51.89% | +19.74% | +19.05% | +13.31% | +9.32% | +0.00% |
| 2025-03-31 | +51.89% | +18.01% | +20.71% | +12.83% | +9.39% | +0.00% |
| 2024-12-31 | +51.89% | +17.99% | +20.54% | +11.89% | +9.58% | +0.00% |
| 2024-09-30 | +51.89% | +17.25% | +21.06% | +11.92% | +9.80% | +0.00% |
| 2024-06-30 | +51.90% | +16.16% | +21.77% | +13.10% | +10.18% | +0.00% |
| 2024-03-31 | +51.92% | +14.68% | +22.21% | +14.28% | +11.19% | +0.00% |
| 2023-12-31 | +51.92% | +14.86% | +21.88% | +13.72% | +11.33% | +0.00% |
| 2023-09-30 | +51.93% | +14.60% | +21.75% | +13.62% | +11.72% | +0.00% |
| 2023-06-30 | +51.93% | +14.70% | +21.23% | +13.20% | +12.14% | +0.00% |
| 2023-03-31 | +51.94% | +14.67% | +21.07% | +13.15% | +12.31% | +0.00% |
| 2022-12-31 | +51.94% | +15.15% | +20.67% | +12.68% | +12.24% | +0.00% |
| 2022-09-30 | +51.94% | +15.40% | +20.78% | +13.62% | +11.87% | +0.00% |
| 2022-06-30 | +51.94% | +0.00% | +36.50% | n/a | n/a | +0.00% |
| 2022-03-31 | +51.94% | +0.00% | +36.77% | n/a | n/a | +0.00% |
| 2021-12-31 | +51.95% | +0.00% | +37.03% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
| MANKIND | MANKIND PHARMA LIMITED | 108,433.48 cr | 47.905015 | +14.41% | +15.86% |
Data snapshot: 2026-11-16. Not investment advice.